克拉霉素与托氟沙星联用治疗支原体衣原体非淋菌性尿道炎疗效观察  

Clarithromycin and tosufloxacin in the treatment of nongonococcal urethritis Mycoplasma pneumoniae curative effect observation

作　　者：黄志娟 

机构地区：[1]广东省佛山市禅城区同济医院,佛山528000

出　　处：《按摩与康复医学》2012年第3期95-96,共2页Chinese Manipulation and Rehabilitation Medicine

摘　　要：目的：探讨克拉霉素与托氟沙星联用治疗支原体衣原体非淋菌性尿道炎的临床效果.方法：将我院2009年8月～2011年1月收治的120支原体衣原体非淋菌性尿道炎患者随机分为克拉霉素组、托氟沙星组合联合组各40例.克拉霉素组给予口服克拉霉素胶囊0.25g,托氟沙星组给予口服托氟沙星胶囊0.3g,联合组口服克拉霉素0.25g、托氟沙星0.3g,疗程14天,观察和对比各组的临床疗效.结果：克拉霉素治疗非淋菌性尿道炎的疗效及复发率与托氟沙星比较差异无显著性（P〉0.05）,联合用药组治疗非淋菌性尿道炎效果显著,复发率低,与克托霉素组和托氟沙星组比较差异有显著性（P〈0.05）.结论：克拉霉素与托氟沙星联合治疗支原体衣原体非淋菌性尿道炎疗效显著、安全、服用方便,不良反应低,复发少.具有高效、安全、服用方便等特点,是一种值得推广的临床技术.Objective：Study of clarithromycin with tosufloxacin in the treatment of Mycoplasma non--gonocoecal urethritis clinical effect. Methods：Will my courtyard in 2009 August to 2011 January were 120 Mycoplasma non--gonococcal urethritis patients were randomly divided into groups,clarithromycin tosufloxacin combination of joint group with 40 cases in each group. Clarithromycin group were given oral clarithromycin capsules 0. 25g, tosufloxacin group were given oral tosufloxacin capsule combined with group 0.3g,0.25g,oral clarithromycin tosufloxacin 0.3g, course of treatment is 14 days,observe and compare the clinical efficacy of each group. Results：Clarithromycin in the treatment of nongonococcal urethritis in therapeutic effects and recurrence rate and tosu-floxacin had no significant differences （ P 〈 0.05 ） ,combination group treatment of nongonococcal urethritis effect,low recurrence rate,and G daptomycin group and tosufloxacin group had significant difference （P 〈 0.05）. Conclusion.. Clarithromycin and tosufloxacin in combined treatment of nongonococcal urethritis Mycoplasma pneumoniae curative effect, safety, convenient use, adverse reactions to low, less recurrence. With high efficiency, safety, convenient use and other characteristics, it is worthy of popularization in clinical techniques.

关 键 词：支原体 衣原体 非淋菌性尿道炎 克拉霉素 托氟沙星 

分 类 号：R4[医药卫生—临床医学]